Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Cash & Equivalents (2016 - 2024)

Historic Cash & Equivalents for Ocugen (OCGN) over the last 12 years, with Q2 2024 value amounting to $15.7 million.

  • Ocugen's Cash & Equivalents fell 7775.94% to $15.7 million in Q2 2024 from the same period last year, while for Jun 2024 it was $15.7 million, marking a year-over-year decrease of 7775.94%. This contributed to the annual value of $39.5 million for FY2023, which is 4912.26% down from last year.
  • Latest data reveals that Ocugen reported Cash & Equivalents of $15.7 million as of Q2 2024, which was down 7775.94% from $26.4 million recorded in Q1 2024.
  • Over the past 5 years, Ocugen's Cash & Equivalents peaked at $129.8 million during Q1 2022, and registered a low of $3.2 million during Q1 2020.
  • Over the past 5 years, Ocugen's median Cash & Equivalents value was $60.9 million (recorded in 2023), while the average stood at $62.3 million.
  • In the last 5 years, Ocugen's Cash & Equivalents skyrocketed by 210606.88% in 2020 and then tumbled by 7775.94% in 2024.
  • Quarter analysis of 5 years shows Ocugen's Cash & Equivalents stood at $24.0 million in 2020, then skyrocketed by 295.02% to $95.0 million in 2021, then dropped by 18.32% to $77.6 million in 2022, then tumbled by 49.12% to $39.5 million in 2023, then tumbled by 60.22% to $15.7 million in 2024.
  • Its Cash & Equivalents stands at $15.7 million for Q2 2024, versus $26.4 million for Q1 2024 and $39.5 million for Q4 2023.